Please see below for information on the 2015 Asian Oncology Summit. I would be grateful if you would include details in any calendar listings either on your website or in member newsletters.

Conference title: 
Asian Oncology Summit 2015
Cause and effect: aetiology and medicine working together to improve health

7th Annual Asian Oncology Summit–held in conjunction with the 11th Annual Conference of the Organisation for Oncology and Translational Research and Viral Hepatitis 2015

Dates: 
April 10-12, 2015

Location: 

Shanghai, China

Special delegate rate for members of Supporting Societies
US$400

Website: 

www.asianoncologysummit.com/

Secretariat:

Marie-Claire Morley, Asian Oncology Summit 2015
Email: m.morley@elsevier.com

Synopsis:

Special member rates are available for delegates attending the Asian Oncology Summit 2015. To qualify: select the member rate and society name during online registration.

The Asian Oncology Summit will comprise multiple parallel suites, each dedicated to different subspecialties. The main topics of the meeting include breast cancer, endocrine-system cancers, gastrointestinal cancer, genitourinary cancer, gynaecological cancer, haematological cancer, head and neck cancer, neuro-oncology, paediatric oncology, thoracic oncology, sarcoma, skin cancer, epidemiology, cancer prevention, and cancer control, supportive and palliative care, molecular imaging, and health-care systems and policy. Each suite will offer a didactic overview on the trends, management, and challenges faced within the Asian context.

The programme will also have plenary lectures by renowned international and regional speakers, and will also feature oral and e-poster presentations of submitted abstracts.

The conference will offer a rare opportunity for oncologists in Asia to come together in an accessible location for interaction with, and learning from, regional opinion leaders and key oncologists from around the world. The mix of speakers will facilitate an authoritative discussion on the local challenges in the field of oncology, and offer an opportunity to develop a consensus on the most appropriate treatment regimens and interventions needed to tackle the growing cancer burden in Asia.